21 CFR 11 Overview of the Final Document and its New Scope Ludwig Huber - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

21 CFR 11 Overview of the Final Document and its New Scope
Ludwig Huber
This article provides an overview of Rule 21 CFR Part 11's key requirements and its new, narrower scope.

Pharmaceutical Technology

3. International Society for Pharmaceutical Engineering (ISPE), The Good Automated Manufacturing Practices (GAMP) Guide for Validating of Automated Systems in Pharmaceutical Manufacture, GAMP4, (ISPE, Tampa, FL, 2001).

4. L. Huber, Validation of Computerized Analytical and Networked Systems, (Interpharm Press/CRC, Boca Raton, FL, 2002).

5. FDA Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Applications (Draft Feb. 2003, Final Aug. 2003). Available at http:// http://www.fda.gov/cder/guidance/5667fnl.pdf.

6. ISPE, The Good Automated Manufacturing Practices (GAMP) Guide: Risk-Based Approach to Compliant Electronic Records and Signatures, (ISPE, Tampa, FL, 2005).

7. J.C. Famulare, "Current Status and Future Directions of Part 11," paper presented Sept 21, 2004.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Pharmaceutical Technology,
Click here